 NEW YORK, May 11, 2021 GLOBE NEWSWIRE -- Delcath Systems, Inc. NASDAQ: DCTH, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the first quarter ended March 31, 2021. 